这是一篇来自已证抗体库的有关人类 EPHB2的综述,是根据16篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合EPHB2 抗体。
EPHB2 同义词: BDPLT22; CAPB; DRT; EK5; EPHT3; ERK; Hek5; PCBC; Tyro5

赛默飞世尔
小鼠 单克隆(1A6C9)
  • 免疫印迹基因敲除验证; 人类; 图 s6b
  • 免疫印迹; 人类; 图 s6b
赛默飞世尔 EPHB2抗体(ThermoFisher, 37-1700)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 s6b) 和 被用于免疫印迹在人类样本上 (图 s6b). MAbs (2021) ncbi
小鼠 单克隆(1A6C9)
  • proximity ligation assay; 非洲爪蛙; 1:100; 图 3e
赛默飞世尔 EPHB2抗体(Thermo Fisher, 37-1700)被用于被用于proximity ligation assay在非洲爪蛙样本上浓度为1:100 (图 3e). elife (2019) ncbi
小鼠 单克隆(1A6C9)
  • 免疫沉淀; 人类; 图 4
赛默飞世尔 EPHB2抗体(Biosource, 1A6C9)被用于被用于免疫沉淀在人类样本上 (图 4). Am J Cancer Res (2015) ncbi
小鼠 单克隆(1A6C9)
  • 免疫印迹; 人类
赛默飞世尔 EPHB2抗体(Invitrogen, 37-1700)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(1A6C9)
  • 免疫印迹; 人类; 1:250; 图 6
赛默飞世尔 EPHB2抗体(Invitrogen, 37-1700)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 6). PLoS ONE (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(2D12C6)
  • 免疫沉淀; 非洲爪蛙; ; 图 1f
  • 免疫印迹; 非洲爪蛙; 1:100; 图 1f
圣克鲁斯生物技术 EPHB2抗体(Santa Cruz, sc130068)被用于被用于免疫沉淀在非洲爪蛙样本上浓度为 (图 1f) 和 被用于免疫印迹在非洲爪蛙样本上浓度为1:100 (图 1f). elife (2019) ncbi
小鼠 单克隆(2D12C6)
  • 免疫印迹基因敲除验证; 人类; 图 6f
圣克鲁斯生物技术 EPHB2抗体(Santa Cruz Biotechnology, 2D12C6)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 6f). J Virol (2018) ncbi
安迪生物R&D
domestic goat 多克隆
  • 免疫组化基因敲除验证; 小鼠; 图 1e
安迪生物R&D EPHB2抗体(R&D Systems, AF467)被用于被用于免疫组化基因敲除验证在小鼠样本上 (图 1e). Clin Sci (Lond) (2021) ncbi
碧迪BD
小鼠 单克隆(16/ERK)
  • 免疫印迹; 小鼠; 1:1000; 图 5c
碧迪BD EPHB2抗体(BD Biosciences, 610123)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5c). Cell Death Dis (2020) ncbi
小鼠 单克隆(16/ERK)
  • 免疫印迹; 小鼠; 图 4a
碧迪BD EPHB2抗体(BD Transduction Laboratories, 16/ERK)被用于被用于免疫印迹在小鼠样本上 (图 4a). J Immunol (2019) ncbi
小鼠 单克隆(16/ERK)
  • 免疫印迹; 人类; 图 2e
碧迪BD EPHB2抗体(BD Biosciences, 16)被用于被用于免疫印迹在人类样本上 (图 2e). Sci Rep (2018) ncbi
小鼠 单克隆(16/ERK)
  • 免疫印迹; 小鼠; 图 3e
碧迪BD EPHB2抗体(BD Biosciences, 610124)被用于被用于免疫印迹在小鼠样本上 (图 3e). Oncogene (2017) ncbi
小鼠 单克隆(16/ERK)
  • 免疫印迹; 人类; 图 6
碧迪BD EPHB2抗体(BD Transduction, 610123)被用于被用于免疫印迹在人类样本上 (图 6). PLoS ONE (2015) ncbi
小鼠 单克隆(16/ERK)
  • 免疫印迹; 人类; 图 2
碧迪BD EPHB2抗体(BD, 610124)被用于被用于免疫印迹在人类样本上 (图 2). Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(16/ERK)
  • 免疫印迹; 小鼠
碧迪BD EPHB2抗体(BD Biosciences, 610123)被用于被用于免疫印迹在小鼠样本上. Mol Cell Biol (2015) ncbi
小鼠 单克隆(16/ERK)
  • 免疫印迹; 人类
碧迪BD EPHB2抗体(BD Transduction Laboratories, 610124)被用于被用于免疫印迹在人类样本上. Oncogene (2015) ncbi
小鼠 单克隆(16/ERK)
  • 免疫印迹; 人类
碧迪BD EPHB2抗体(BD, 610123)被用于被用于免疫印迹在人类样本上. J Am Heart Assoc (2013) ncbi
文章列表
  1. Huang Z, Liu S, Tang A, Al Rabadi L, Henkemeyer M, Mimche P, et al. Key role for EphB2 receptor in kidney fibrosis. Clin Sci (Lond). 2021;135:2127-2142 pubmed 出版商
  2. Enderle L, Shalaby K, Gorelik M, Weiss A, Blazer L, Paduch M, et al. A T cell redirection platform for co-targeting dual antigens on solid tumors. MAbs. 2021;13:1933690 pubmed 出版商
  3. Coccia E, Planells Ferrer L, Badillos Rodríguez R, Pascual M, Segura M, Fernández Hernández R, et al. SIVA-1 regulates apoptosis and synaptic function by modulating XIAP interaction with the death receptor antagonist FAIM-L. Cell Death Dis. 2020;11:82 pubmed 出版商
  4. Koppers M, Cagnetta R, Shigeoka T, Wunderlich L, Vallejo Ramirez P, Qiaojin Lin J, et al. Receptor-specific interactome as a hub for rapid cue-induced selective translation in axons. elife. 2019;8: pubmed 出版商
  5. Simonović N, Witalisz Siepracka A, Meissl K, Lassnig C, Reichart U, Kolbe T, et al. NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity. J Immunol. 2019;202:1724-1734 pubmed 出版商
  6. TerBush A, Hafkamp F, Lee H, Coscoy L. A Kaposi's Sarcoma-Associated Herpesvirus Infection Mechanism Is Independent of Integrins α3β1, αVβ3, and αVβ5. J Virol. 2018;92: pubmed 出版商
  7. Vanshylla K, Bartsch C, Hitzing C, Krümpelmann L, Wienands J, Engels N. Grb2 and GRAP connect the B cell antigen receptor to Erk MAP kinase activation in human B cells. Sci Rep. 2018;8:4244 pubmed 出版商
  8. Goreczny G, Ouderkirk Pecone J, Olson E, Krendel M, Turner C. Hic-5 remodeling of the stromal matrix promotes breast tumor progression. Oncogene. 2017;36:2693-2703 pubmed 出版商
  9. Oprea T, Sklar L, Agola J, Guo Y, Silberberg M, Roxby J, et al. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases. PLoS ONE. 2015;10:e0142182 pubmed 出版商
  10. Dubois F, Leroy C, Simon V, Benistant C, Roche S. YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells. Am J Cancer Res. 2015;5:1972-87 pubmed
  11. Kwon H, Lee J, Jeong K, Jang D, Pak Y. Fatty acylated caveolin-2 is a substrate of insulin receptor tyrosine kinase for insulin receptor substrate-1-directed signaling activation. Biochim Biophys Acta. 2015;1853:1022-34 pubmed 出版商
  12. Wiesauer I, Gaumannmüller C, Steinparzer I, Strobl B, Kovarik P. Promoter occupancy of STAT1 in interferon responses is regulated by processive transcription. Mol Cell Biol. 2015;35:716-27 pubmed 出版商
  13. Eriksson O, Ramström M, Hörnaeus K, Bergquist J, Mokhtari D, Siegbahn A. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa. J Biol Chem. 2014;289:32379-91 pubmed 出版商
  14. Yim D, Ghosh S, Guy G, Virshup D. Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling. Oncogene. 2015;34:474-84 pubmed 出版商
  15. Dai J, Buhusi M, Demyanenko G, Brennaman L, Hruska M, Dalva M, et al. Neuron glia-related cell adhesion molecule (NrCAM) promotes topographic retinocollicular mapping. PLoS ONE. 2013;8:e73000 pubmed 出版商
  16. Xiong Y, Yu Y, Montani J, Yang Z, Ming X. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. J Am Heart Assoc. 2013;2:e000096 pubmed 出版商